The effect of etodolac on bile salt and histamine-mediated gastric mucosal injury in the rat

Journal of Physiology Paris

Volumn 95, Issue 1-6, 2001, Pages 43-49

  Abdel Salam, Omar M E ^a   El Shenawy, Siham ^a   El Batran, Seham ^a   Arbid, Mahmoud S ^a   Mózsik, Gyula ^b  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b UNIVERSITY OF PÉCS   (Hungary)

Author keywords

COX 2; Etodolac; Gastric acid; Gastric ulcer; Rat stomach

Indexed keywords

BILE SALT; CYCLOOXYGENASE 2 INHIBITOR; ETODOLAC; HISTAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; TAUROCHOLIC ACID;

ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; DIGESTIVE SYSTEM ULCER; DOSE RESPONSE; DRUG EFFECT; DRUG INDUCED DISEASE; FEMALE; MALE; NONHUMAN; RAT; STOMACH ACID SECRETION; STOMACH MUCOSA; STOMACH ULCER;

ANESTHESIA; ANIMALS; CHOLAGOGUES AND CHOLERETICS; CYCLOOXYGENASE INHIBITORS; ETODOLAC; FEMALE; GASTRIC ACID; GASTRIC MUCOSA; HISTAMINE; MALE; MUCUS; RATS; RATS, SPRAGUE-DAWLEY; TAUROCHOLIC ACID; URETHANE;

EID: 0034747731     PISSN: 09284257     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-4257(01)00008-0     Document Type: Conference Paper

References (42)

1. 2 and carbenoxolone
2. The changing gastrointestinal side effect profile of non-steroidal anti-inflammatory drugs. A new approach for the prevention of a new problem
3. Misoprostol, a synthetic PGE1 analog, in the treatment of duodenal ulcers. A multicenter double-blind study
4. Clinical spectrum of the upper gastrointestinal effects of nonsteroidal anti-inflammatory drugs. Natural history, symptomatology, and significance
5. A method for the quantitative estimation of gastric mucosal barrier
6. 2
7. Tissue selective inhibition of prostaglandin biosynthesis by etodolac
8. 2
9. Gastroduodenal mucosal secretion of bicarbonate and mucus. Physiologic control and stimulation by prostaglandins
10. Aspirin and the risk of colorectal cancer in women
11. Non-steroidal anti-inflammatory drugs and peptic ulcers
12. Gastrointestinal complications of nonsteroidal anti-inflammatory drugs: Prophylactic and therapeutic strategies
13. Chemoprevention of colorectal cancer
14. Gastric vascular actions of prostanoids and the dual effect of arachidonic acid
15. Preventive effect of atropine on indomethacin-induced gastrointestinal mucosal and vascular damage in rats
16. Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs
17. 2, and cimetidine on hemodynamics and metabolic rate in canine gastric mucosa
18. Major upper gastrointestinal tract bleeding. Relation to the use of aspirin and other non-narcotic analgesics
19. 2 on the surface hydrophobicity of aspirin-treated canine gastric mucosa
20. Unresolved issues in the role of cyclooxygenase-2 in normal physiologic processes and disease
21. Medical treatment for stroke prevention
22. Nonsteroidal anti-inflammatory drugs-The clinical dilemmas
23. Gastroduodenal mucosal defense: Factors responsible for the ability of the stomach and duodenum to resist injury
24. 2 and ethanol
25. Beneficial effects of NSAIDs in the gastrointestinal tract
26. Cellular mechanisms of the development of gastric mucosal damage and of gastric cytoprotection induced by prostacyclin in rats. A pharmacological study
27. Gastroduodenal ulceration in rabbits producing antibodies to prostaglandins
28. Relationship of gastric mucosal damage induced in pigs by antiinflammatory drugs to their effects on prostaglandin production
29. 2
30. Biochemical and pharmacological profile of a tetra-substituted furanone as a highly slective COX-2 inhibitor
31. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HC1, NaOH, hypertonic NaC1 and thermal injury
32. 2-induced secretion of surfactant phospholipid by isolated gastric mucous cells
33. Non-steroidal anti-inflammatory drugs (NSAIDs) and gastro-intestinal toxicity: Current issues
34. NSAID use and decreased risk of gastrointestinal cancers
35. Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-like drugs
36. Mechanism of action of aspirin-like drugs
37. Mechanism of action of nonsteroidal anti-inflammatory drugs
38. Prophylactic aspirin and risk of peptic ulcer bleeding
39. Differential action of parentral aspirin and salicylate on the cat gastric antrum
40. Neuronal and endothelium-derived mediators in the modulation of the gastric microcirculation: Integrity in the balance
41. Selective inhibition of prostaglandin production in inflammatory exudates and gastric mucosa
42. Non-steroidal anti-inflammatory drug gastropathy and cytoprotection: Pathogenesis and mechanisms re-examined